|
AnalytiCon Discovery is a qualified and reliable partner in the field of target-to-lead discovery.
Our growing compound screening and profiling portfolio covers state-of-the-art cell-based
and biochemical assays addressing requested or novel therapeutic drug targets such as
G-protein-coupled receptors or protein kinases as well as protein-protein interaction,
functional, and phenotypic approaches.
- UV/Vis photometry (absorbance)
- Fluorescence (top & buttom read)
- Chemiluminescence
- Time-Resolved Fluorescence (TRF)
- Fluorescence Polarisation (FP)
|
